clinical practice
them cope with a diagnosis of cancer and
get through the demands of treatment.
So there’s a program of work that looks
at that, with women with metastatic
breast cancer, people affected by
pancreatic cancer, and people living with
multiple myeloma.
We really are trying to find these groups
of patients who we know have suboptimal
outcomes in terms of their cancer diagnosis
because of the complexity of the disease.
There’s a program of work where we’ve
been doing core design studies with
patients and their family members to say,
“Actually, what sort of interventions do you
need to help you manage?”
It could be the informational challenges
of a complex cancer diagnosis and all
of these new novel therapies, or what
you need to manage the cognitive
decline that comes with the treatments,
or the pain that’s associated with some
cancer diagnoses.
Then there’s a program of work that is
looking at developing our skills as nurses,
particularly nurses who have cancer
knowledge, but developing skills on caring
for older adults with cancer.
We know we’re an ageing population; we
know that’s where the majority of cancer
diagnoses are; and yet the challenges
facing somebody who may have
comorbidities, or may be at risk of frailty
because of their cancer, or their cancer
treatments, are particularly challenging.
So, we’re looking at developing new
interventions, and then testing those to
see what the impact of that is on the
quality of care that is then delivered to
these older adults.
We’re also working with the older adults
themselves on a core design study to say,
“What do you need nurses to know about
caring for you when you’re older with a
diagnosis of cancer?”
So we’re really using the experts’
experience to drive our programs and
research, and to inform the system
changes we need.
Then the final program we’re working on
is looking at the workforce. We know we
have this remarkable workforce of nurses.
But we also know that by 2025 we’ll be
around 85,000 nurses short in Australia.
So how do we profile the impact and
importance of specialist cancer nurses
to make sure that resource-strapped
organisations are investing in these nurses?
That we can carry out studies to show the
contribution of expert clinical decision-
making, of being able to triage complex
and less complex patients, so that we’re
really directing our expertise to those
patients who need us most, but also, who
have the greatest capacity to benefit from
interaction with specialist nurses.
The breadth of programs allows nurses
who are interested in many different things
to tap into our programs and say, “I’d really
like to know more about research, and I’d
like to do it in that program of work.”
How does it work when a nurse
approaches you? Is it run through the
university, or through their hospital?
There are a couple of different ways. A
lot of it is informal. I’m very lucky to have
access across the clinical partners, so a lot
of it is conversations with nurses on a day-
to-day basis. The other way is people may
contact me formally through the university
website, either through the Department of
Nursing or the Centre for Cancer Research
at the University of Melbourne.
But very excitingly, we just got a new
initiative that’s being funded by the
Victorian government, through the VCCC,
which is a million-dollar investment for
a nurse-led cancer innovation research
hub, which will allow us to engage with
nurses, both face to face, but also online
and flexibly, so that they can learn research
skills. But really, importantly, they can also
apply to spend 12 weeks with us in the
research hub to learn skills, and to think
about how they would use those skills for
a project that has been prioritised by their
organisation, as something that is really
important for the care of people and in the
organisation they come from.
The hub also has seed funding for
research grants. So we will say to nurses,
“If you can pitch an idea that has real
resonance with your organisation, and
importantly with at least one of the VCCC
organisations, we will give you seed funding
to kickstart that program of research work.”
In your time in academia, how have
things changed in the way we teach
students cancer nursing?
I think things are changing really quickly.
For a long time we’ve been fairly stable –
I’m trying not to say stagnant – in the way
we’ve approached teaching cancer nurses.
It’s been quite didactic. It’s been heavily
classroom-based.
What we’re seeing, in lots of
organisations, and what we’re investing
in at the University of Melbourne at
the moment, is taking content that is
appropriate and relevant to take online, so
that we can begin to bring cancer nurses
education that is flexible, that is there for
them at point of delivery, when they can
get to it, but also allows them to access it in
the clinical environment.
So they can maybe look at a quick three
or four-minute learning module about
how to talk to a person about exercise and
cancer if they’re not sure how to introduce
the conversation.
So there’s a shift in mode of delivery,
but I think the critical piece is that we’ve
seen an enormous shift in two of the big
domains, the first being that we actually
have to embed the voice of the patient and
the consumer in our education.
We have to make the experience of
having a cancer diagnosis and treatment
real for nurses, because the more we can
do that, the greater we will hone people
skills of empathy, communication and
the desire to support people, which we
know from the data we have mastered is
fundamentally important to the quality of
care; the people see that experience of
care, but also they have constant care.
Nurses are quite
research naive. There
are few of us who have
doctoral or postdoctoral
studies.
The other piece that we’ve seen shift
exponentially is we have this incredible,
remarkable advancement in cancer
therapy. So we have immunotherapies,
targeted therapies, these new CAR T-cells.
We have remarkable technological
changes in radiation therapy. We are doing
surgery that we could only have dreamed
of 5–10 years ago.
With that comes a complexity around the
patients that we’ve never seen before. We
are getting older patients, people who are
coming in with far advanced disease, and
we’re seeing these people thankfully live
much longer.
But they live longer with consequences
of complex therapy, so we’re having to
teach nurses not just the acute care of
people with cancer, but survivorship care,
complex long-term comorbidity care and,
importantly, expert, exquisite end-of-life
care and the communications that go
with that. ■
nursingreview.com.au | 23